课题基金 / 基金详情

CARNITINE PALMITOYLTRANSFERASE AND FATTY ACID METABOLISM

CARNITINE PALMITOYLTRANSFERASE AND FATTY ACID METABOLISM
肉碱棕榈酰转移酶和脂肪酸代谢
批准号:
2430176
负责人:
DANIEL W FOSTER
金额:
$41.72万
依托单位国家:
美国
项目类别:
财政年份:
1975
资助国家:
美国
项目状态:
已结题
起止时间:
1975-06-01 至 1998-05-31

项目摘要

项目成果

DANIEL W FOSTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The mitochondrial carnitine palmitoyltransferase (CPT) enzyme system (composed of CPT I, CPT II and a translocase component) plays a pivotal role in the regulation of fatty acid metabolism in mammalian tissues. Recently it has received increasing attention as a potential site for pharmacological intervention in hyperglycemic states, and is now recognized as a locus of human mutations, some with serious consequences. For a number of years we have sought to unravel the complexities of the CPT isozymes, and during the past grant period have uncovered some novel and unexpected features surrounding their biochemical and functional properties. Using cloning techniques we have now reached the threshold of an exciting era that promises to shed new light on the subject at a molecular level (e.g., for the first time we have obtained the complete amino acid sequence of a CPT enzyme). Continuing in this vein our overall objectives are to elucidate the actual structures of the rat and human CPT proteins, their regulatory properties, the organization of their genes, and the nature of inherited defects in enzyme activity. Four main questions will be posed: (1) How do the primary amino acid sequences of CPT I and CPT II compare in different tissues? (2) How do CPT I and CPT II interact with their respective membranes, substrates and inhibitors? (3) How do the rat genes for CPT I and CPT II compare in number and structure? (4) How do the human CPT genes and gene products relate to their rat counterparts, and what is the genetic basis for the inherited CPT deficiency syndromes? Answers to these questions would transform current understanding of mitochondrial fatty acid transport from the realm of vague, operational definitions to one of concrete, biochemical principles. In addition, the information gained could lead to diagnostic, and possibly therapeutic, advances in the arena of disease states characterized by excessive or inadequate rates of fatty acid oxidation.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/s0021-9258(18)53392-5
发表时间: 1993-03
期刊: The Journal of biological chemistry
影响因子: --
作者: [V. Esser;C. Britton;B. Weis;D. W. Foster;J. McGarry]
通讯作者: V. Esser;C. Britton;B. Weis;D. W. Foster;J. McGarry
Clarification of the nucleotide sequence at the 5'-end of the cDNA for rat liver carnitine palmitoyltransferase II.
大鼠肝肉毒碱棕榈酰转移酶 II cDNA 5 端核苷酸序列的澄清。
DOI: 10.1042/bj2960271
发表时间: 1993
期刊: The Biochemical journal
影响因子: --
作者: [Weis,BC, Foster,DW, McGarry,JD]
通讯作者: McGarry,JD
Expression, purification, and reconstitution of rat liver carnitine palmitoyltransferase I.
大鼠肝脏肉毒碱棕榈酰转移酶 I 的表达、纯化和重建。
DOI: 10.1385/1-59259-400-x:281
发表时间: 2003
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Brown,NicholasF]
通讯作者: Brown,NicholasF
DOI: --
发表时间: 1994
期刊: The Journal of biological chemistry
影响因子: --
作者: [Brown,NF, Anderson,RC, Caplan,SL, Foster,DW, McGarry,JD]
通讯作者: McGarry,JD
15
    PROGRAM TO PREVENT TYPE I DIABETES
    • 批准号:
      6248726
    • 项目类别:
    • 资助金额:
      $3.01万
    • 财政年份:
      1997
    • 负责人:
      DANIEL W FOSTER
    • 依托单位:
    PROGRAM TO PREVENT TYPE I DIABETES
    • 批准号:
      6278702
    • 项目类别:
    • 资助金额:
      $2.47万
    • 财政年份:
      1997
    • 负责人:
      DANIEL W FOSTER
    • 依托单位:
    ENDOCRINE & METABOLISM TRAINING GRANT
    • 批准号:
      2733880
    • 项目类别:
    • 资助金额:
      $15.79万
    • 财政年份:
      1978
    • 负责人:
      DANIEL W FOSTER
    • 依托单位:
    ENDOCRINE & METABOLISM TRAINING GRANT
    • 批准号:
      2134817
    • 项目类别:
    • 资助金额:
      $14.02万
    • 财政年份:
      1978
    • 负责人:
      DANIEL W FOSTER
    • 依托单位:
    国内基金
    海外基金
    L-carnitine调控红细胞S1P释放治疗青光眼的机制探究
    • 批准号:
      2025JJ60575
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李彦秀
    • 依托单位:
    基于“肠道菌群-Carnitine代谢-白色脂肪棕色化”途径研究苓桂术甘汤治疗肥胖症的作用机制
    • 批准号:
      82104716
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      杨玉彬
    • 依托单位:
    基于“肠道菌群-Carnitine代谢-白色脂肪棕色化”途径研究苓桂术甘汤治疗肥胖症的作用机制
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      30万元
    • 批准年份:
      2021
    • 负责人:
      杨玉彬
    • 依托单位:
    L-carnitine(左旋肉碱)在视网膜色素上皮细胞-间充质细胞转换过程中的作用及机制研究
    • 批准号:
      81500727
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2015
    • 负责人:
      李敏
    • 依托单位: